Survival benefit of D2 lymphadenectomy in patients with gastric adenocarcinoma

Annals of Surgical Oncology

Volumn 7, Issue 3, 2000, Pages 210-217

  Oñate Ocaña, Luis F ^a   Aiello Crocifoglio, Vincenzo ^a   Mondragón Sánchez, Ricardo ^a   Ruiz Molina, Juan M ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Gastric adenocarcinoma; Lymphadenectomy; Prognostic factors; Splenectomy and pancreatectomy; Surgical morbidity

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PANCREAS RESECTION; PROGNOSIS; SPLENECTOMY; STOMACH ADENOCARCINOMA; STOMACH CANCER;

EID: 0342313557     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02523656     Document Type: Article

References (30)

1. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol 1996;23:360-8.
2. Siewert JR, Roder JD, Böttcher K, et al, the German Gastric Carcinoma Study Group. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993;80: 1015-8.
3. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric cancer. Br J Surg 1988;75:110-2.
4. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-8.
5. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH, and the Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-14.
6. Cuschieri A, Payers P, Fielding J, and the Surgical Cooperative Group. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 1996;347:995-9.
7. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial: Surgical Co-operative Group. Br J Cancer 1999;79:1522-30.
8. Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on long-term survival. J Am Coll Surg 1997;185:177-84.
9. Kwon SJ. Prognostic impact of splenectomy on gastric cancer: results of the Korean Gastric Cancer Study Group. World J Surg 1997;21:837-44.
10. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1981;11:127-45.
11. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma (English ed 1). Tokyo: Kanehara, 1995.
12. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for Staging of Cancer. 4th ed. Philadelphia: J.B. Lippincott, 1992: 63-7.
13. Kaplan EL, Meier PM. Nonparametric estimation from incomplete observations. J Am Stat Soc 1958;53:457-81.
14. Feinstein AR. Multiple logistic regression. In: Multivariable Analysis: An Introduction. New Haven, CT: Yale University Press, 1996:297-330.
15. Feinstein AR. Proportional hazards analysis (Cox regression). In: Multivariable Analysis: An Introduction. New Haven, CT: Yale University Press, 1996:370-97.
16. Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM, Gallardo-Rincon D. Prognostic factors in 793 cases of gastric cancer. Rev Gastroenterol Mex 1999;64:114-21.
17. Secretaria de Salud. Estomago. In: Compendio del Registro Histopatologico de Neoplasias Malignas en Mexico. Mexico: Direccion General de Epidemiologia, 1994:59.
18. Robertson CS, Chung SCS, Woods SDS, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176-82.
19. Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study. Ann Surg 1989;209:162-6.
20. Noguchi Y, Imada T, Matsumoto A, Coit DG, Brennan MF. Radical surgery for gastric cancer: a review of the Japanese experience. Cancer 1989;64:2053-62.
21. Bunt AMG, Hogendoorn PCW, van de Velde CJH, Bruijn JA, Hermans J. Lymph node staging standards in gastric cancer. J Clin Oncol 1995;13:2309-16.
22. Roder JD, Bonenkamp JJ, Craven J, et al. LND for gastric cancer in clinical trials: update. World J Surg 1995;19:546-53.
23. Bunt AMG, Hermans J, Smit VTH, van de Velde CJH, Fleuren GJ, Bruijn JA. Surgical/pathological-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995;13:19-25.
24. Bunt AMG, Hermans J, van de Velde CJH, et al. Lymph node retrieval in a randomized trial on Western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol 1996;14:2289-94.
25. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995;19:532-6.
26. Sasako M, McCulloch P, Kinoshita T, Maruyama K. A new method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995; 82:346-51.
27. Roukos DH, Encke A, Lorenz M. Evidence of survival benefit of extended (D2) LND in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery 1998;123:573-8.
28. Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-7.
29. Kodera Y, Yamamura Y, Shimizu Y, et al. Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer. J Am Coll Surg 1997;185:65-9.
30. Pacelli F, Doglietto GB, Bellantone F, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 1993;80: 1153-6.